MYELODYSPLASTIC SYNDROME (MDS)/AML

Clinical trials for MYELODYSPLASTIC SYNDROME (MDS)/AML explained in plain language.

Never miss a new study

Get alerted when new MYELODYSPLASTIC SYNDROME (MDS)/AML trials appear

Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS)/AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Terminated 1

New 'Living Drug' trial targets tough blood cancers

Disease control Not yet recruiting

This is a first-in-human study testing a new type of CAR T-cell therapy for adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, genetically…

Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)/AML

Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

MYELODYSPLASTIC SYNDROME (MDS)/AML

Get alerted when new MYELODYSPLASTIC SYNDROME (MDS)/AML trials appear

New 'Living Drug' trial targets tough blood cancers